Form 8-K - Current report:
SEC Accession No. 0001564590-20-045968
Filing Date
2020-10-07
Accepted
2020-10-07 08:40:19
Documents
3
Period of Report
2020-10-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20201007.htm 8-K 38574
2 EX-99.1 abio-ex991_6.htm EX-99.1 18910
3 GRAPHIC gvivbclcwj1d000001.jpg GRAPHIC 20861
  Complete submission text file 0001564590-20-045968.txt   87710
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 201228119
SIC: 2835 In Vitro & In Vivo Diagnostic Substances